These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3688330

  • 1. [Indicators of cellular immunity in patients with ovarian cancer and methods of their correction].
    Stambrovskaia AA, Siparov IN.
    Akush Ginekol (Mosk); 1987 Jul; (7):43-6. PubMed ID: 3688330
    [No Abstract] [Full Text] [Related]

  • 2. [Inhibition of leucocyte migration in women with ovarian carcinoma, and its dependence on the quantity of lymphocytes forming E-rosettes (author's transl)].
    Tosner J, Vejbora O, Fixa B.
    Cas Lek Cesk; 1981 Sep 24; 120(38):1150-4. PubMed ID: 7273087
    [No Abstract] [Full Text] [Related]

  • 3. [Use of ovarian carcinoma tissue culture in the leukocyte migration inhibition test].
    Tosner J, Fixa B, Jirkalová V, Donát J.
    Cas Lek Cesk; 1987 Apr 03; 126(14):439-41. PubMed ID: 3581139
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ, Bhatti RA, Guinan PD.
    Cancer Res; 1978 Nov 03; 38(11 Pt 1):3702-6. PubMed ID: 698929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S.
    Acta Obstet Gynaecol Jpn; 1981 Jul 03; 33(7):1015-24. PubMed ID: 6171133
    [Abstract] [Full Text] [Related]

  • 10. Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity.
    Bhatti RA, Ablin RJ, Guinan PD.
    Eur J Cancer (1965); 1979 Jan 03; 15(1):133-6. PubMed ID: 421713
    [No Abstract] [Full Text] [Related]

  • 11. Cellular immunity in patients with colorectal adenocarcinoma measured by autologous leukocyte migration inhibition.
    Elias EG, Elias LL, Didolkar MS, Hebel JR.
    Cancer; 1977 Aug 03; 40(2):687-92. PubMed ID: 890653
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G, Kademann J.
    Arch Geschwulstforsch; 1980 Aug 03; 50(2):169-72. PubMed ID: 7436701
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ, Storch H.
    Zentralbl Gynakol; 1986 Aug 03; 108(10):593-606. PubMed ID: 3526755
    [Abstract] [Full Text] [Related]

  • 18. [Leukocyte adherence in women with ovarian carcinoma].
    Kobilková J, Jandová A, Pokorný J, Macků J.
    Ceska Gynekol; 1994 Apr 03; 59(2):66-9. PubMed ID: 8004373
    [Abstract] [Full Text] [Related]

  • 19. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
    Kochetkova VA.
    Lab Delo; 1980 Apr 03; (12):744-6. PubMed ID: 6163894
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.